Clinical Trial: Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Rapamycin Therapy of Angiomyolipomas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis

Brief Summary: The purpose of this study was to determine if rapamycin reduced angiomyolipomata volume in patients with tuberous sclerosis complex or lam.